{
  "id": 2337,
  "url": "https://nnemf.org/research/2337-activation-of-signaling-cascades-by-weak-extremely-low",
  "title": "Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic",
  "authors": [],
  "journal": "",
  "year": "2017",
  "doi": "10.1159/000481977",
  "pmid": null,
  "abstract": "Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields Kapri-Pardes E, Hanoch T, Maik-Rachline G, Murbach M, Bounds PL, Kuster N, Seger R. Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields. Cell Physiol Biochem. 2017 Oct 16;43(4):1. doi: 10.1159/000481977. Abstract BACKGROUND/AIMS: Results from recent studies suggest that extremely low frequency magnetic fields (ELF-MF) interfere with intracellular signaling pathways related to proliferative control. The mitogen-activated protein kinases (MAPKs), central signaling components that regulate essentially all stimulated cellular processes, include the extracellular signal-regulated kinases 1/2 (ERK1/2) that are extremely sensitive to extracellular cues. Anti- phospho-ERK antibodies serve as a readout for ERK1/2 activation and are able to detect minute changes in ERK stimulation. The objective of this study was to explore whether activation of ERK1/2 and other signaling cascades can be used as a readout for responses of a variety of cell types, both transformed and non- transformed, to ELF-MF. METHODS: We applied ELF-MF at various field strengths and time periods to eight different cell types with an exposure system housed in a tissue culture incubator and followed the phosphorylation of MAPKs and Akt by western blotting. RESULTS: We found that the phosphorylation of ERK1/2 is increased in response to ELF-MF. However, the phosphorylation of ERK1/2 is likely too low to induce ELF-MF-dependent proliferation or oncogenic transformation. The p38 MAPK was very slightly phosphorylated, but JNK or Akt were not. The effect on ERK1/2 was detected for exposures to ELF-MF strengths as low as 0.15 µT and was maximal at ∼10 µT. We also show that ERK1/2 phosphorylation is blocked by the flavoprotein inhibitor diphenyleneiodonium, indicating that the response to ELF-MF may be exerted via NADP oxidase similar to the phosphorylation of ERK1/2 in response to microwave radiation. CONCLUSIONS: Our results further indicate that cells are responsive to ELF-MF at field strengths much lower than previously suspected and that the effect may be mediated by NADP oxidase. However, the small increase in ERK1/2 phosphorylation is probably insufficient to affect proliferation and oncogenic transformation. Therefore, the results cannot be regarded as proof of the involvement of ELF-MF in cancer in general or childhood leukemia in particular. https://www.ncbi.nlm.nih.gov/pubmed/29035881",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Eight different cell types (transformed and non-transformed)",
    "sampleSize": "—",
    "exposure": "ELF · various time periods",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Across eight cell types, ELF-MF exposure increased ERK1/2 phosphorylation; p38 MAPK was very slightly phosphorylated, while JNK and Akt were not. ERK1/2 phosphorylation was detected at field strengths as low as 0.15 µT and was maximal at approximately 10 µT; the ERK1/2 response was blocked by diphenyleneiodonium, suggesting involvement of NADP oxidase. The authors state the ERK1/2 increase is likely too small to induce ELF-MF-dependent proliferation or oncogenic transformation and is not proof of involvement of ELF-MF in cancer or childhood leukemia.",
    "outcomes": [
      "ERK1/2 phosphorylation",
      "p38 MAPK phosphorylation",
      "JNK phosphorylation",
      "Akt phosphorylation",
      "Cell proliferation (inference/assessment)",
      "Oncogenic transformation (inference/assessment)",
      "Effect of diphenyleneiodonium (flavoprotein inhibitor) on ERK1/2 phosphorylation"
    ],
    "limitations": [
      "Frequency of ELF-MF not specified in the abstract",
      "Sample sizes/replicates not reported in the abstract",
      "Proliferation/oncogenic transformation were not demonstrated",
      "conclusions about these outcomes are based on the magnitude of signaling changes"
    ],
    "keywords": [
      "extremely low frequency magnetic fields",
      "ELF-MF",
      "MAPK",
      "ERK1/2",
      "p38",
      "JNK",
      "Akt",
      "phosphorylation",
      "western blot",
      "NADP oxidase",
      "diphenyleneiodonium",
      "cell signaling"
    ],
    "hubs": [
      {
        "slug": "occupational-exposure",
        "weight": "0.7",
        "reason": "Study examines ELF magnetic-field strengths in the µT range, which can be relevant to occupational ELF exposures, though no specific source is described."
      }
    ],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"various time periods\"\n  },\n  \"population\": \"Eight different cell types (transformed and non-transformed)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"ERK1/2 phosphorylation\",\n    \"p38 MAPK phosphorylation\",\n    \"JNK phosphorylation\",\n    \"Akt phosphorylation\",\n    \"Cell proliferation (inference/assessment)\",\n    \"Oncogenic transformation (inference/assessment)\",\n    \"Effect of diphenyleneiodonium (flavoprotein inhibitor) on ERK1/2 phosphorylation\"\n  ],\n  \"main_findings\": \"Across eight cell types, ELF-MF exposure increased ERK1/2 phosphorylation; p38 MAPK was very slightly phosphorylated, while JNK and Akt were not. ERK1/2 phosphorylation was detected at field strengths as low as 0.15 µT and was maximal at approximately 10 µT; the ERK1/2 response was blocked by diphenyleneiodonium, suggesting involvement of NADP oxidase. The authors state the ERK1/2 increase is likely too small to induce ELF-MF-dependent proliferation or oncogenic transformation and is not proof of involvement of ELF-MF in cancer or childhood leukemia.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Frequency of ELF-MF not specified in the abstract\",\n    \"Sample sizes/replicates not reported in the abstract\",\n    \"Proliferation/oncogenic transformation were not demonstrated; conclusions about these outcomes are based on the magnitude of signaling changes\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low frequency magnetic fields\",\n    \"ELF-MF\",\n    \"MAPK\",\n    \"ERK1/2\",\n    \"p38\",\n    \"JNK\",\n    \"Akt\",\n    \"phosphorylation\",\n    \"western blot\",\n    \"NADP oxidase\",\n    \"diphenyleneiodonium\",\n    \"cell signaling\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"occupational-exposure\",\n      \"weight\": 0.2,\n      \"reason\": \"Study examines ELF magnetic-field strengths in the µT range, which can be relevant to occupational ELF exposures, though no specific source is described.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://www.ncbi.nlm.nih.gov/pubmed/29035881",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=2337",
  "updated": "2026-02-10 12:32:33"
}